Log In
Print
BCIQ
Print
Print this Print this
 

MK-5172

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionOral HCV NS3/4A protease complex inhibitor
Molecular Target HCV NS3/4A protease complex
Mechanism of ActionViral protease inhibitor
Latest Stage of DevelopmentPhase II
IndicationHepatitis C virus (HCV)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today